Two Sigma Investments
ANTH

Two Sigma Investments’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Two Sigma Investments’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,515
Closed -$23K – 2477
2014
Q3 		$23K Buy
+1,515
New +$31.9K ﹤0.01% 1704

Other funds holding ANTH

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Two Sigma Investments's ANTH Position: Q4 2014 in Review

Two Sigma Investments sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q4 2014, closing a stake of 1,515 shares — an estimated $23K sold.

Two Sigma Investments first reported a position in ANTH in Q3 2014 and held it in 1 quarter. The position peaked at $23K in Q3 2014. 37 funds tracked by Wall St. Rank hold ANTH as of Q4 2014.

  • Two Sigma Investments reported no remaining Anthera Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Two Sigma Investments sold 1,515 Anthera Pharmaceuticals, Inc. shares in Q4 2014, an estimated $23K.
  • Two Sigma Investments first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2014 and held it in 1 quarter.
  • Two Sigma Investments's Anthera Pharmaceuticals, Inc. position peaked at $23K in Q3 2014.
  • 37 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q4 2014.

Based on Two Sigma Investments's 13F filing for Q4 2014, filed 17 Feb 2015.